谷歌Alpha家族再登Nature封面！刷新基因组预测SOTA，精准定位远端致病突变

Core Viewpoint - Google DeepMind's new model, AlphaGenome, expands AI's predictive capabilities to the complex realm of the human genome, achieving state-of-the-art (SOTA) performance in genomic predictions [1][9]. Group 1: Model Capabilities - AlphaGenome can simultaneously predict 11 different gene regulatory processes, capturing complex interactions within genes [3][11]. - The model accurately analyzes gene splicing mechanisms, identifying how a single gene can produce multiple proteins and when errors occur that lead to diseases [4][8]. - It has demonstrated the ability to predict mutations related to diseases, such as accurately reconstructing pathogenic mutations in the TAL1 gene associated with leukemia [6][23]. Group 2: Performance Metrics - AlphaGenome has achieved SOTA performance in 22 out of 24 evaluations related to genomic trajectory predictions and outperformed existing models in 25 out of 26 direct disease association tasks [14][9]. - The model's predictive performance includes a 49% success rate in identifying regulatory directions for GWAS-related variants, significantly surpassing traditional methods [21]. Group 3: Technical Architecture - The model employs a hybrid architecture combining CNN and Transformer technologies, allowing for high-precision genomic predictions [30][31]. - AlphaGenome's input window extends to 1 million base pairs, enabling it to cover most interactions between remote enhancers and promoters [36]. - The training process utilizes a large-scale dataset covering both human and mouse genomes, ensuring the model learns universal rules of gene regulation across different physiological environments [37][38]. Group 4: Training Strategy - AlphaGenome implements a two-phase training strategy to balance generalization and inference efficiency, including a pre-training phase with strict cross-validation and a distillation phase for model refinement [40][41]. - The training incorporates rigorous data augmentation strategies to enhance the model's robustness against unseen mutations [43].